Evidence map›Paper›PMID 38643196›Full record

ArticleScientific reports2024

Apigetrin ameliorates doxorubicin prompted testicular damage: biochemical, spermatological and histological based study.

Muhammad Umar Ijaz, Saba Yaqoob, Ali Hamza, Mehwish David, Tayyaba Afsar, Fohad Mabood Husain, Houda Amor, Suhail Razak

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Muhammad Umar IjazDepartment of Zoology, Wildlife and Fisheries, University of Agriculture, Faisalabad, 38040, Pakistan. umar.ijaz@uaf.edu.pk.
Saba YaqoobDepartment of Zoology, Wildlife and Fisheries, University of Agriculture, Faisalabad, 38040, Pakistan.
Ali HamzaDepartment of Zoology, Wildlife and Fisheries, University of Agriculture, Faisalabad, 38040, Pakistan.
Mehwish DavidDepartment of Animal Sciences, Quaid-I-Azam University, Islamabad, 45320, Pakistan.
Tayyaba AfsarDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 2455, 11451, Riyadh, Saudi Arabia.
Fohad Mabood HusainDepartment of Food Science and Nutrition, College of Food and Agriculture Sciences, King Saud University, Riyadh, Saudi Arabia.
Houda AmorDepartment of Obstetrics, Gynecology and Reproductive Medicine, Saarland University Clinic, Homburg, Germany.
Suhail RazakDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 2455, 11451, Riyadh, Saudi Arabia.
King Saud University · SAUniversity of Agriculture Faisalabad · PKQuaid-i-Azam University · PKSaarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Doxorubicin (DOX) is a highly effective, commonly prescribed, potent anti-neoplastic drug that damages the testicular tissues and leads to infertility. Apigetrin (APG) is an important flavonoid that shows diverse biological activities. The present research was designed to evaluate the alleviative role of APG against DOX-induced testicular damages in rats. Forty-eight adult male albino rats were randomly distributed into 4 groups, control, DOX administered (3 mgkg

Indexed as

ApigeninOxidative StressSemenAnimalsAntioxidantsDoxorubicinMaleRatsRats, WistarTestisTestosteroneAntioxidantsApigeninapigetrinDoxorubicinTestosteroneApigetrinApoptosisDoxorubicinOxidative stressTesticular damage

Identifiers

PMID38643196
PMCPMC11555402
OpenAlexW4394978034

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.